Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.What are the subtypes of NSCLC?Squamous cell carcinoma is found in cells that line the airways of the lungs. It is usually found in the middle of the lung. Adenocarcinoma is found in cells that produce mucus. It...
Non-small-cell lung cancer is the most common type of lung cancer. It's serious, but treatment can sometimes cure it or stop it from getting worse. WebMD explains.
Stage 2non-small cell lung cancer(NSCLC) is localized cancer that has not spread beyond one lung or the locallymph nodeson the same side of the chest. Any lung cancer diagnosis is serious, but being in thisearly stagemeans your disease is very treatable, and your chances for a long-term...
Non-small cell lung cancer (NSCLC) remains an ongoing health concern, with poor treatment options and prognosis for many patients. Typically, individuals with lung cancer are detected at the middle and terminal stages, resulting in poor medical results due to lack of initial diagnosis and treatment...
Non-small-cell lung cancer (NSCLC) has a median onset at age 70 years and is therefore often seen in the elderly [3]. This review aims to provide advice on issues that are frequently faced when managing elderly patients with NSCLC. These include decisions on which treatment is the best ...
Nintedanib for the treatment of non-small-cell lung cancer. In NSCLC, increased microvessel count, often used as a measure of angiogenesis, has been correlated with poor prognosis and associated with advanced diseas... Sawsan,Rashdan,Nasser,... - 《Expert Opinion on Pharmacotherapy》 被引量: ...
Historically, there are many hard-to-treat mutations of non-small cell lung cancer. Whitney E. Lewis, PharmD, BCOP,a clinical pharmacy specialist at the University of Texas MD Anderson Cancer Center, Houston, Texas, discusses novel therapeutics for patients with non-sma...
Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.. Bakirhan K,Sharma J,Perez-Soler R,et al. Current Treatment Options in Oncology . 2016Bakirhan K, Sharma J, Perez-Soler R, et al. Medical Treat- ment in Elderly Patients with Non-Small Cell Lung Can- cer [J]. ...
Lung Cancer, 72, 265-70.Fruh M. The search for improved systemic therapy of non-small cell lung cancer—what are today’s options? Lung Cancer. ... Früh,M. - 《Lung Cancer》 被引量: 54发表: 2011年 Second-line treatment options in Non-Small Cell Lung Cancer (NSCLC): report from ...
Non-small cell lung cancer (NSCLC) is the main subtype of lung cancer, andpemetrexed(PEM) resistance limits its treatment[20]. Multiple studies showed thatHDAC1, which can regulate H3K18cr in cancer development, was upregulated in clinical NSCLC tissues and correlated with poor pro...